A Study to Assess Safety, Tolerability, and Pharmacokinetics of MEDI0382 in Non-diabetic Obese Participants
Clinical trial NCT03625778 · COMPLETED
Trial details
- NCT number
- NCT03625778
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-14
- Primary completion
- 2019-08-25
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.